Symptom dimensions in obsessive-compulsive disorder: Implications for the DSM-V

CNS Spectrums

Volumn 12, Issue 5, 2007, Pages

  Leckman, James F ^a   Rauch, Scott L ^b   Mataix Cols, David ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN BLOOD FLOW; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPULSION; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS V; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; FACTORIAL ANALYSIS; FAMILY LIFE; FAMILY STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC LINKAGE; HUMAN; MENTAL DISEASE; META ANALYSIS; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PERSONALITY DISORDER; PHENOTYPE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RELIGION; REVIEW; SEXUAL BEHAVIOR; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TRICHOTILLOMANIA; YALE BROWN OBSESSIVE COMPULSIVE SCALE SYMPTOM CHECKLIST;

EID: 34249892550     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900021179     Document Type: Review

References (98)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text rev. Washington, DC: American Psychiatric Association; 2000.
2. International Classification of Diseases. Geneva. Switzerland: World Health Organization; 1992.
3. Hantouche EG, Lancrenon S. Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients [French]. Encephale. 1993;22:9-21.
4. Rachman SJ, Hodgson RJ. Obsessions and Compulsions. Englewood Cliffs, NJ: Prentice-Hall; 1980.
5. Khanna S, Mukherjee D. Checkers and washers: valid subtypes of obsessive compulsive disorder. Psychopathology. 1992;25:283-288.
6. Horesh N, Dolberg OT, Kirschenbaum-Aviner N, Kotler M. Personality differences between obsessive-compulsive disorder subtypes: washers versus checkers. Psychiatry Res. 1997;71:197-200.
7. Matsunaga H, Kiriike N, Matsui T, et al. A comparative study of clinical features between pure checkers and pure washers cetegorized using a lifetime symptom rating method. Psychiatry Res. 2001;105:221-228
8. Goodman WK, Price LH, Resmussen SA et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006-1011.
9. Baer L. Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry. 1994;55(suppl):18-23.
10. Leckman JF, Grice DE, Boardmen J, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154:911-917.
11. Leckman JF, Walker W K, Goodman WK, Pauls DL, Cohen DJ. "Just right" perceptions associated with compulsive behaviors in Tourette's syndrome. Am J Psychiatry. 1994;151:675-680.
12. Pauls DL, Alsobrook J, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive compulsive disorder. Am J Psychiatry. 1995;152:76-84.
13. Summerfeldt LJ, Richter MA, Antony MM, Swinson RP. Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study. Behav Res Ther. 1999;37:297-311.
14. Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005;162:228-238.
15. Hasler G, LeSalle-Ricci VH, Ronquillo JG, et al. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res. 2005;135:121-132
16. Hasler G, Kazuba D, Murphy DL. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2006;141:403-408.
17. Denys D, de Geus F, van Megen HJ, Westenberg HG. Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology. 2004;37:181-189.
18. Denys D, de Geus F, van Megen HJ, Westenberg HG. Use of factor analysis to detect potentiel phenotypes in obsessive-compulsive disorder. Psychiatry Res. 2004;128:273-280.
19. Summerfeldt LJ, Kloosterman PH, Antony MM, Richter MA, Swinson RP. The relationship between miscellaneous symptoms and major symptom factors in obsessive-compulsive disorder. Behav Res Ther. 2004;42:1453-1467.
20. Kim BN, Lee CB, Hwang JW, Shin MS, Cho SC. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea. J Child Adolesc Psychopharmacol. 2005;15:318-324.
21. Delorme R, Billo A, Betancur C, et al. Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study. BMC Psychiatry. 2006;8:1.
22. McKay D, Piacentini J, Greisberg S, Graae F, Jaffer M, Miller J. The structure of childhood obsessions and compulsions: dimensions in an outpatient sample. Behav Res Ther. 2006;44:137-146.
23. Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet. 2002;114:347-353.
24. Leckman JF, Pauls DL, Zhang H, et al. Obsessive-compulsive symptom dimensions in effected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet. 2003;118:60-68.
25. McKay D, Abramowitz JS, Calamari JE, et al. A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms. Clin Psychol Rev. 2004;24:283-313.
26. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409-1416.
27. Tek C, Ulug B. Religiosity and religious obsessions in obsessive-compulsive disorder. Psychiatry Res. 2001;104:99-108.
28. Mataix-Cols D, Merks IM, Greist JH. Kobak KA, Beer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from s controlled trial. Psychother Psychosom. 2002;71:255-262.
29. Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002;14:485-496.
30. Feinstein SB, Fallon BA, Patkova E, Liebowitz MR. Item-by-item factor analysis of the Yale-Brawn Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci. 2003;15:187-193.
31. Rosario-Campos MC, Miguel EC, Quatrano S, et al. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry. 2006;11:495-504.
32. Rettew DC, Swedo SE, Leonard HL, Lenane MC. Rapoport JL. Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1992;31:1050-1056.
33. Mataix-Cols D, Rauch SL, Baer L, et al. Symptom stability in adult obsessive compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry. 2002;159:263-268.
34. Rufer M, Grothusen A, Mass R, Peter H, Hand I. Temporal stability of symptom dimensions in adult patients with obsessive-compulsive disorder. J Affect Disord. 2005;88:99-102.
35. Helmi KA, Sunday SR, Klump K, et al. Obsessions and compulsions in anorexia nervosa subtypes. Int J Eat Disord. 2003;33:308-319.
36. Halmi KA, Tozzi F, Thornton LM, et al. The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders. Int J Eat Disord. 2005;36:371-374.
37. Mataix-Cols D, Baer L, Rauch SL, Jenike MA. Relation of factor-analyzed symptom dimensions of obsessive-compulsive disorder to personality disorders. Acta Psychiatr Scand. 2000;102:199-202.
38. Frost RO, Steketee G, Williams LF, Warren R. Mood, personality disorder symptoms and disability in obsessive-compulsive hoarders: a comparison with clinical and nonclinical controls. Behav Res Ther. 2000;38:1071-1081.
39. Samuels J, Bienvenu OJ 3rd, Riddle MA, et al. Hoarding in obsessive compulsive disorder results from a case-control study. Behav Res Ther. 2002;40:517-528.
40. Saxena S, Maidment KM, Vepnik T, et al. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry. 2002;63:21-27.
41. Hasler G, Pinto A, Greenberg BD, et al. Familiarity of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry. 2007;61:617-625.
42. Alsobrook II JP, Pauls DL. Molecular approaches to child psychopathology. Hum Biology. 1998;70:413-432.
43. Nicolini H, Kuthy I, Hernandez E, Velazquez F. A family study of obsessive-compulsive disorder in Mexican population. Am J Hum Genet Suppl. 1991;49:477-447.
44. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive-compulsive disorder and related disorders. Am J Med Genet. 1999;88:38-43.
45. Alcais A, Abel L. Maximum-Likelihood-Binomial method for genetic model-free linkage analysis of quantitative traits in sibships. Genet Epidemiol. 1999;17:102-117.
46. Gu C, Province M, Todorov A, Rao DC. Meta-analysis methodology for combining non-parametric sibpair linkage results: genetic homogeneity and identical markers. Genet Epidemiol. 1998;15:609-626.
47. Zheng H, Risch N. Mapping quantitative-trait loci in humans by use of extreme concordant sib pairs: selected sampling by parental phenotypes. Am J Hum Genet 1996;59:951-957.
48. Alsobrook II JP, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet. 1999;88:669875.
49. Hanna GL, Fischer DJ, Chadha KR, Himle JA, Van Etten M. Familial and sporadic subtypes of early-onset obsessive-compulsive disorder. Biol Psychiatry. 2005;57:895-900.
50. Zhang H, Leckman JF, Tsai CP, Kidd KK, Rosario-Campos MC. Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet. 2002;70:896-904.
51. Hu XZ, Lipsky RH, Zhu G, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78:815-826.
52. Sutcliffe JS, Delahanty RJ, Prasad HC, et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet. 2005;77:265-279.
53. Lawrence NS, Wooderson S, Mataix-Cols D, David R, Speckens A, Phillips ML. Decision making and set shifting impairments are associated with distinct symptom dimensions in obsessive-compulsive disorder. Neuropsychology. 2006;20:409-419.
54. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563-586.
55. Rauch SL, Dougherty DD, Shin LM, et al. Neural correlates of factor-analyzed OCD symptom dimension: a PET study. CNS Spectr. 1998;3:37-43.
56. Phillips ML, Marks IM, Senior C, et al. A differential neural response in obsessive-compulsive patients with washing compered with checking symptoms to disgust. Psych Med. 2000;30:1037-1060.
57. Shapira NA, Liu Y, He AG, et al. Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry. 2003;54:751-756.
58. Van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al. Amygdale activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Res. 2004;132:225-237.
59. Saxena S, Brody AL, Maidment KM, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry. 2004;161:1038-1048.
60. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61:564-576.
61. Lawrence NS, An SK, Mataix-Cols D, Ruths F, Speckens A, Phillips ML, Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychiatry. In press.
62. Rauch SL, Wedig MM, Wright CI, et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry. 2007;61:330-336.
63. Pujol J, Soriano-Mas C, Alonso P, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61:720-730.
64. Mataix-Cols D, Fullana MA, Alonso P, Menchon JM, Vellejo J. Convergent and discriminant validity of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist. Psychother Psychosom. 2004;73:190-196.
65. Hollander E, Bienstock CA, Koran LM, et al. Refractory obsessive-compulsive disorder state-of-the-art treatment. J Clin Psychiatry. 2002;63:20-29.
66. Black DW, Monahen P, Gable J, Blum N, Clency G, Baker P. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry. 1996;59:420-425.
67. Winsberg ME, Cassic KS, Koran LM. Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry. 1999;60:591-597.
68. Erzegovesi S, Cavallini MC, Cavedini P, Diaferia G, Locatelli M, Bellodi L. Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol. 2001;21:488-492.
69. Saxena S, Brody AL, Maidment KM, Baxter LR Jr. Paroxetine treatment of compulsive hoarding. J Psychiatr Res. 2007;41:481-487.
70. Alonso MP, Menchón JM, Pifarré J, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry. 2001;62:535-540.
71. Ferrão YA, Shavitt RG, Bedin NR, et al. Clinical features associated to treatment response in obsessive-compulsive disorder. J Affect Disord. 2006;94:199-209.
72. Shetti CN, Reddy YC, Kandavel T, et al. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. J Clin Psychiatry. 2005;68:1517-1523.
73. Jenike MA, Baer L, Minichiello WE, Rauch SL, Buttolph ML. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry. 1997;154:1261-1264.
74. Baer L, Rauch SL, Ballantine HT, et al. Cingulotomy for intractable obsessive compulsive disorder: prospective long-term follow-up of 18 patients. Arch Gen Psychiatry. 1995;52:384-392.
75. Basoglu M, Lax T, Kasvikis Y, Marks IM. Predictors of improvement in obsessivecompulsive disorder. J Anxiety Disord. 1988;2:299-317.
76. Foa EB, Goldstein A. continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behav Ther. 1978;9:821-829.
77. Christensen H, Hadzai-Pavlovic D, Andrews G, Mattick R. Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol. 1967;55:701-711.
78. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol. 2003;71:1049-1057.
79. Ball SG, Baer L, Otto MW. Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther. 1996;34:47-51.
80. Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptom dimensions in obsessive-compulsive disorder prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand. 2006;113:440-446.
81. Gesell A, Ilg F. Infant and Child in the Culture of Today. The Guidance of Development in Home and Nursery School. New York, NY: Harper & Brothers Publishers; 1943.
82. Evans DW, Leckman JF, Carter A, Reznick JS, Henshew D, Pauls DL. Ritual, habit and perfactionism: the prevalence and development of compulsive like behavior in normal young children. Child Dev. 1997;68:58-68.
83. Zohar AH, Falz L. Ritualistic behavior in young children. J Abnorm Child Psychol. 2001;29:121-128.
84. Evans DW, Gray FL, Leckman JF. The rituals, fears and phobias of young children: insights from development, psychopathology and neurobiology. Child Psychiatry Hum Dev. 1999;29:261-276.
85. Leckman JF, Mayes LC. Understanding developmental psychopathology: how useful are evolutionary perspectives? J Am Acad Child Adolesc Psychiatry. 1998;37:1011-1021.
86. Feygin DL, Swain JE, Leckman JF. The normalcy of neurosis: evolutionary origins of obsessive-compulsive disorder and related behaviors. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:854-864.
87. Bracha HS. Human brain evolution and the "Neuroevolutionary Time-depth Principle": implications for the reclassification of fear-circuitry-related traits in DSM-V and for studying resilience to warzone-related posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:827-853.
88. Leckman JF, Mayes LC, Feldman R, Evans D, King RA, Cohen DJ. Early parental preoccupations and behaviors and their possible relationship to the symptoms of obsessive-compulsive disorder. Acta Psychiatr Scand Suppl. 1999;396:1-26.
89. Maser JD, Patterson T. Spectrum and nosology: implications for DSM-V. Psychiatr Clin North Am. 2002;25:855-885.
90. Darwin CR. On the Origin of the Species By Means of Natural Selection, or the Preservation of Favored Races in the Struggle for Life. London, UK: John Murray; 1859.
91. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993;13:354-358.
92. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloparidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302-308.
93. Leckman JF, Grice DE, Berr LC, et al. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety. 1994-1995;1:208-215.
94. Grados MA, Riddle MA, Samuels JF, et al. The familiel phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol Psychiatry. 2001;50:559-565.
95. Rosario-Campos MC, Leckman JF, Mercadante MT, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158:1899-1903.
96. Wewetzer C, Jans T, Muller B, et al. Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence. Eur Child Adolesc Psychiatry. 2001;10:37-46.
97. de Mathis MA, Diniz JB, do Rosario MC, et al. What is the optimal way to subdivide obsessive-compulsive disorder? CNS Spectr. 2006;11:762-779.
98. Coles ME, Pinto A, Mancebo MC, Rasmussen SA, Eisen JL. OCD with comorbid OCPD: a subtype of OCD? J Psychiatr Res. 2007 Mar 22; [Epub ahead of print].